机译:现实世界实践中早期肝细胞癌的治疗选择:治疗阶段迁移对霉变化疗栓塞和治疗响应的影响
Alfred Hosp Dept Gastroenterol Melbourne Vic Australia;
Alfred Hosp Dept Gastroenterol Melbourne Vic Australia;
Eastern Hlth Dept Gastroenterol Melbourne Vic Australia;
Austin Hosp Dept Gastroenterol Heidelberg Vic Australia;
St Vincents Hosp Dept Gastroenterol Fitzroy Vic Australia;
Eastern Hlth Dept Gastroenterol Melbourne Vic Australia;
Monash Med Ctr Dept Gastroenterol Clayton Vic Australia;
Univ Melbourne Austin Hosp Dept Surg Heidelberg Vic Australia;
Royal Melbourne Hosp Dept Gastroenterol Parkville Vic Australia;
Monash Med Ctr Dept Gastroenterol Clayton Vic Australia;
St Vincents Hosp Dept Gastroenterol Fitzroy Vic Australia;
Monash Univ Alfred Hosp Sch Publ Hlth &
Prevent Med Dept Epidemiol &
Prevent Med Clin Haematol;
Monash Med Ctr Dept Gastroenterol Clayton Vic Australia;
Alfred Hosp Dept Gastroenterol Melbourne Vic Australia;
Alfred Hosp Dept Gastroenterol Melbourne Vic Australia;
BCLC 0/A; survival; treatment stage migration;
机译:现实世界实践中早期肝细胞癌的治疗选择:治疗阶段迁移对霉变化疗栓塞和治疗响应的影响
机译:前瞻性队列研究:极早期和早期肝细胞癌患者的经动脉化疗栓塞
机译:Cryarterial Chemoembolization与碘125种子与晶促化疗栓塞联合射频消融治疗早期和中期肝细胞癌的治疗
机译:改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
机译:倍半萜类药物可作为肝细胞癌(HCC)的潜在治疗方法:在大鼠HCC肿瘤模型中,通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
机译:Cryarterial Chemoembolization与碘125种子与晶促化疗栓塞联合射频消融治疗早期和中期肝细胞癌的治疗
机译:Callisberes®Microshizesrelisterpheres®微球的治疗响应,存活和安全性与肝细胞癌中的常规常规化疗栓塞:Meta分析